Bibliographic Details
| Title: |
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group |
| Authors: |
Le Gouill, Steven *, Beldi-Ferchiou, Asma *, Alcantara, Marion *, Cacheux, Victoria, Safar, Violaine, Burroni, Barbara, Guidez, Stéphanie, Gastinne, Thomas, Canioni, Danielle, Thieblemont, Catherine, Maisonneuve, Hervé, Bodet-Milin, Caroline, Houot, Roch, Oberic, Lucie, Bouabdallah, Krimo, Bescond, Charles, Damaj, Ghandi, Jaccard, Arnaud, Daguindau, Nicolas, Moreau, Anne, Tilly, Hervé, Ribrag, Vincent, Delfau-Larue, Marie-Hélène, Hermine, Olivier, Macintyre, Elizabeth |
| Source: |
In The Lancet Haematology November 2020 7(11):e798-e807 |
| Database: |
ScienceDirect |
